Treatment with yohimbine, and the resulting elevation of serum insulin levels, completely prevented PDE4 inhibitor-induced hyperglycemia (Figure 5A), thus further demonstrating that PDE4 inhibition does not reduce whole-body insulin sensitivity but acts via an insulin-independent mechanism to elevate blood glucose levels. The gene discussed is INS; the disease is Hyperglycemia.